[
Bedell, S. L., Goldstein, L. S., Goldstein, A. R., Goldstein, A. T. (2020). Cervical cancer screening: Past, present, and future. Sex Med., 8 (1), 28–37.10.1016/j.sxmr.2019.09.00531791846
]Search in Google Scholar
[
Bedoya, A. M., Jaramillo. R., Baena, A., Castano, J., Olaya, N., Zea, A. H., Herrero, R., Sanchez, G. I. (2013). Location and density of immune cells in precursor lesions and cervical cancer. Cancer Microenviron., 6 (1), 69–77.10.1007/s12307-012-0097-8360121522290207
]Search in Google Scholar
[
Brenton, J. D., Ellenson, L. H., Gilks, C. B., Herrington, C. S. (2019). WHO Classification of Tumours. 5th edition. Vol. 4. WHO. Lyon, 632 pp.
]Search in Google Scholar
[
Brito, M. J., Sequeira, P., Silva, I., Quintas, A., Martins, C., Félix, A. (2021). CD4 + and CD8 + cell populations in HIV-positive women with cervical squamous intra-epithelial lesions and squamous cell carcinoma. Int. J. Infect. Dis., 103, 370–377.10.1016/j.ijid.2020.10.08333157285
]Search in Google Scholar
[
Bonin, C. M., Padovani, C. T. J., da Costa, I. P, Ávila, L. S., Ferreira, A. M. T., Fernandes, C. E. S., Dos Santos, A. R., Tozetti, I. A. (2018). Detection of regulatory T cell phenotypic markers and cytokines in patients with human papillomavirus infection, J. Med. Virol., 91, 2, 317–325.10.1002/jmv.25312
]Search in Google Scholar
[
Das, D., Sarkar, B., Mukhopadhyay, S., Banerjee, C., Biswas, S. M. (2018). An altered ratio of CD4+ and CD8+ T lymphocytes in cervical cancer tissues and peripheral blood — a prognostic clue? Asian Pac. J. Cancer Prev., 19 (2), 471.
]Search in Google Scholar
[
Gholami, D. M., Kardar, G. A., Saeedi, Y., Heydari, S., Garssen, J., Falak, R. (2017). Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms. Cell Immunol., 322,1–14.10.1016/j.cellimm.2017.10.00229079339
]Search in Google Scholar
[
Gurrola-Diaz, C. M., Suarez-Rincon, A. E., Vazquez-Camacho, G., Buonocunto-Vazquez, G., Rosales-Quintana, S., Wentzensen, N., von Knebel Doeberitz, M. (2008). P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies. Gynecol. Oncol., 111, 120–124.10.1016/j.ygyno.2008.06.03218692882
]Search in Google Scholar
[
Guzm an-Olea, E., Bermu dez-Morales, V. H., Peralta-Zaragoza, O., Torres-Poveda, K., Madrid-Marina, V. (2012). Molecular mechanism and potential targets for blocking HPV-induced lesion development. J. Oncol., 20, 278312.10.1155/2012/278312
]Search in Google Scholar
[
Kojima, S., Kawana, K., Tomio, K., Yamashita, A., Taguchi, A., Miura, S., Adachi, K., Nagamatsu, T., Nagasaka, K., Matsumoto, Y., et al. (2013). The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN. Amer. J. Reprod. Immunol., 69 (2), 134–141.10.1111/aji.1203023057776
]Search in Google Scholar
[
Loddenkemper, C., Hoffmann, C., Stanke, J., Nagorsen, D., Baron, U., Olek, S., Huehn, J., Ritz, J. P., Stein, H., Kaufmann, A. M., Schneider, A., Cichon, C. (2009). Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci., 100 (6), 1112–1117.10.1111/j.1349-7006.2009.01153.x19514119
]Search in Google Scholar
[
Litwin, T. R., Irvin, S. R., Chornock, R. L., Sahasrabuddhe, V. V., Stanley, M., Wentzensen, N. (2021). Infiltrating T-cell markers in cervical carcinogenesis: A systematic review and meta-analysis. Brit. J. Cancer., 124 (4), 831–841.10.1038/s41416-020-01184-x788459233257839
]Search in Google Scholar
[
Martin, C. M., O’Leary, J. J., Phil, D. (2011). Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract. Res. Clin. Obstet. Gynaecol., 25, 605–615.10.1016/j.bpobgyn.2011.04.005
]Search in Google Scholar
[
Maskey, N., Thapa, N., Maharjan, M., Shrestha, G., Maharjan, N., Cai, H., Liu, S. (2019). Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu. Cancer Manag Res., 14 (11), 7647-–7655.10.2147/CMAR.S217264669860431616181
]Search in Google Scholar
[
Molina, M. A., Carosi Diatricch, L., Castany Quintana, M., Melchers, W. J., Andralojc, K. M. (2020). Cervical cancer risk profiling: Molecular biomarkers predicting the outcome of hrHPV infection. Expert Rev. Mol. Diagn., 20 (11), 1099–1120.10.1080/14737159.2020.183547233044104
]Search in Google Scholar
[
Monnier-Benoit, S., Mauny, F., Riethmuller, D., Guerrini, J. S., Cãpîlna, M., Félix, S., Seillès, E., Mougin, C., Prétet, J. L. (2006). Immunohisto-chemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol., 102 (1), 22–31.10.1016/j.ygyno.2005.11.03916427684
]Search in Google Scholar
[
Nguyen, H. H., Broker, T. R., Chow, L. T., Alvarez, R. D., Vu, H. L., Andrasi, J., Brewer, L. R., Jin, G., Mestecky, J. (2005). Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol., 96 (2), 452–461.10.1016/j.ygyno.2004.10.01915661235
]Search in Google Scholar
[
Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., Kühnel, F., Woller, N. (2018). CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell Mol. Life Sci., 75, 689.10.1007/s00018-017-2686-7576982829032503
]Search in Google Scholar
[
Øvestad, I. T., Gudlaugsson, E., Skaland, I., Malpica, A., Kruse, A. J., Janssen, E. A, Baak, J. P. (2010). Local immune response in the micro-environment of CIN2-3 with and without spontaneous regression. Mod. Pathol., 23 (9),1231–1240.10.1038/modpathol.2010.10920512116
]Search in Google Scholar
[
Ozaki, S., Zen, Y., Inoue, M. (2011). Biomarker expression in cervical intraepithelial neoplasia: Potential progression predictive factors for low-grade lesions. Hum. Pathol., 42,1007–1012.10.1016/j.humpath.2010.10.02121315414
]Search in Google Scholar
[
Shang, B., Liu, Y., Jiang, S. J., Liu, Y (2015). Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep., 5,15179.10.1038/srep15179460447226462617
]Search in Google Scholar
[
Shibata, T., Lieblong, B. J., Sasagawa, T., Nakagawa, M. (2019). The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer. Cancer Treatment Rev., 10, 1016.10.1016/j.ctrv.2019.07.001671012331302573
]Search in Google Scholar
[
Schorge, J. O., Lea, J. S., Elias, K. J., Rajanbabu, R., Coleman, R. L., Miller, D. S., Ashfaq, R. (2004). p16 as a molecular biomarker of cervical adenocarcinoma. Amer. J. Obstet. Gynecol., 190, 668–673.10.1016/j.ajog.2003.09.03815041997
]Search in Google Scholar
[
Tainio, K., Athanasiou, A., Tikkinen, K. A. O., Aaltonen, R., Cárdenas, J., Hernándes Glazer-Livson, S., Jakobsson, M., Joronen, K., Kiviharju, M., et al. (2018). Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: Systematic review and meta-analysis. Brit. Med. J., 360, k499.10.1136/bmj.k499582601029487049
]Search in Google Scholar
[
Trifonova, R. T., Lieberman. J., van Baarle, D. (2014). Distribution of immune cells in the human cervix and implications for HIV transmission. Amer. J. Reprod. Immunol., 71 (3), 252–64.10.1111/aji.12198394353424410939
]Search in Google Scholar
[
Van Niekerk, D., Guillaud, M., Matisic, J., Benedet, J. L., Freeberg, J. A., Follen, M., MacAulay, C. (2007). p16 and MIB1improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: Methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing. Gynecol. Oncol., 107, S233–240.10.1016/j.ygyno.2007.07.064
]Search in Google Scholar
[
Vattai, A., Kremer, N., Meister, S., Beyer, S., Keilmann, L., Hester, A., Temelkov, M., Heidegger, H., Schmoeckel, E., Kessler, M., Mahner, S., Jeschke, U., Hertlein, L., Kolben, T. (2021). Role of FoxP3-positive regulatory T cells in regressive and progressive cervical dysplasia. J. Cancer Res. Clin. Oncol., 148 (2), 377–386. doi: 10.1007/s00432-021-03838-6.10.1007/s00432-021-03838-634739585
]Search in Google Scholar
[
Weston, G., Dombrowski, C., Harvey, M. J., Iftner, T., Kyrgiou, M., Founta, C., Adams, E. J. (2020). Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: A decision tree model based economic evaluation. BMJ Open, 10 (3), e031303.10.1136/bmjopen-2019-031303706407132152154
]Search in Google Scholar
[
Zheng, Hu., Ding, Ma. (2018). The precision prevention and therapy of HPV-related cervical cancer: New concepts and clinical implications. Cancer Med., 7 (10), 5217–5236.10.1002/cam4.1501
]Search in Google Scholar
[
Yang, H., Ye, S., Goswami, S., Li, T., Wu, J., Cao, C., Ma, J., Lu, B., Pie, X., Chen, Y., Yu, J., Xu, H., Qiu, L., Afridi, S., Xiang, L., Zhang, X. (2020). Highly immunosuppressive HLADRhi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma. Int. J. Cancer, 146 (7), 1993–2006.10.1002/ijc.3278231709528
]Search in Google Scholar